[1]何媛梅,黄楚乔,邓兆燕,等.腹膜透析相关性腹膜炎的细菌谱及耐药性分析[J].医学信息,2020,33(16):135-137.[doi:10.3969/j.issn.1006-1959.2020.16.042]
　HE Yuan-mei,HUANG Chu-qiao,DENG Zhao-yan,et al.Analysis of Bacterial Spectrum and Drug Resistance of Peritonitis Associated with Peritoneal Dialysis[J].Medical Information,2020,33(16):135-137.[doi:10.3969/j.issn.1006-1959.2020.16.042]
点击复制

腹膜透析相关性腹膜炎的细菌谱及耐药性分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年16期
页码:
135-137
栏目:
调查分析
出版日期:
2020-08-15

文章信息/Info

Title:
Analysis of Bacterial Spectrum and Drug Resistance of Peritonitis Associated with Peritoneal Dialysis
文章编号:
1006-1959（2020）16-0135-03
作者:
何媛梅; 黄楚乔; 邓兆燕; 等
（玉林市第一人民医院肾内科，广西 玉林 537000）
Author(s):
HE Yuan-mei; HUANG Chu-qiao; DENG Zhao-yan; et al
(Department of Nephrology,Yulin First People’s Hospital,Yulin 537000,Guangxi,China)
关键词:
腹膜透析; 腹膜炎; 致病菌; 耐药性
Keywords:
Peritoneal dialysis; Peritonitis; Pathogenic bacteria; Drug resistance
分类号:
R446.5；R692.5
DOI:
10.3969/j.issn.1006-1959.2020.16.042
文献标志码:
A
摘要:
目的 探讨腹膜透析相关性腹膜炎（PDAP）致病菌谱和药物敏感性变化情况，为临床合理防治PDAP提供参考依据。方法回顾性收集2015年1月1日~2018年12月31日在玉林市第一人民医院肾内科治疗的PDAP患者110例，分析PDAP患者透出液的致菌谱和致病菌耐药性。结果 患者透出液细菌培养阳性率为30.00%，其中革兰阳性菌占45.45%，革兰阴性菌占42.42%，真菌占12.12%；革兰阳性菌对青霉素的耐药率最高（93.33%），对苯唑西林、左旋氧氟沙星耐药率也较高，分别为78.57%、35.71%，对万古霉素、利奈唑胺均敏感。革兰阴性菌对庆大霉素、左旋氧氟沙星的耐药率分别为61.54%、57.14%，所有菌株对碳青霉烯类药物以及哌拉西林/他唑巴坦、头孢他啶敏感。结论 我院PDAP患者透出液细菌培养阳性率较高，建议临床不再使用头孢唑林和庆大霉素作为PDAP的一线用药，应结合实际检测结果，重新评估经验性抗生素的使用。
Abstract:
Objective To explore the pathogenic bacteria spectrum and drug sensitivity changes of peritoneal dialysis-associated peritonitis (PDAP), and to provide a reference for the reasonable clinical prevention and treatment of PDAP.Methods A retrospective collection of 110 PDAP patients who were treated in the Department of Nephrology, Yulin First People’s Hospital from January 1, 2015 to December 31, 2018, were analyzed for the pathogenic spectrum and pathogenic bacteria resistance of PDAP patients’ fluid.Results The positive rate of bacterial culture in the patient’s exudate was 30.00%, of which gram-positive bacteria accounted for 45.45%, gram-negative bacteria accounted for 42.42%, and fungi accounted for 12.12%; gram-positive bacteria had the highest resistance rate to penicillin (93.33%). The resistance rates to oxacillin and levofloxacin were also high, 78.57% and 35.71% respectively, and they were sensitive to vancomycin and linezolid. The resistance rates of gram-negative bacteria to gentamicin and levofloxacin were 61.54% and 57.14%, respectively.All strains were sensitive to carbapenems, piperacillin/tazobactam, and ceftazidime.Conclusion The positive rate of bacterial culture in the permeate of PDAP patients in our hospital is relatively high. It is recommended that cefazolin and gentamicin should not be used clinically as first-line drugs for PDAP. The use of empirical antibiotics should be reassessed in light of actual test results.

参考文献/References:

[1]方小敏,方舒,胡玉生,等.腹膜透析相关性腹膜炎患者易感病原菌及耐药性分析[J].临床合理用药杂志,2015(26):25-26.[2]Hsieh YP,Chang CC,Wang SC,et al.Predictors for and impact of high peritonitis rate in Taiwanese continuous ambulatory peritoneal dialysis patients[J].International Urology & Nephrology,2015,47(1):183.[3]Htay H,Cho Y,Pascoe EM,et al.Center Effects and Peritoneal Dialysis Peritonitis Outcomes: Analysis of a National Registry[J].American Journal of Kidney Diseases,2017:S0272638617310752.[4]Li PK,Szeto CC,Piraino B,et al.ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment[J].Perit Dial Int,2016,36(5):481-508.[5]王婵媛.PCR和传统培养法检测腹膜透析相关性腹膜炎致病菌的对比分析[J].中华肾脏病杂志,2015,31(12):898-904.[6]张燕敏,王增四,万胜,等.改良法提高腹膜透析液致病菌培养阳性率的临床观察[J].中国血液净化,2015,14(2):82-84.[7]周萍,王少清,高芳,等.单中心五年腹膜透析相关性腹膜炎病原菌及耐药性分析[J].海南医学,2018,29(21):3031-3034.[8]赵丽娟,柏明,何丽洁,等.腹膜透析相关性腹膜炎致病菌谱及危险因素分析[J].疑难病杂志,2019,18(11):1108-1112.[9]叶元君,张晓辉,刘延苏,等.腹膜透析患者居家环境和腹膜炎关系研究[J].浙江医学,2017,39(14):1198-1202.[10]佟怡婧,严豪,李振元,等.711例次腹膜透析相关性腹膜炎的致病菌谱变化及药物敏感分析[J].中华肾脏病杂志,2017,33(8):601-608.[11]杨丽,龚妮容,刘宏发,等.腹膜透析相关性腹膜炎的细菌谱及耐药性分析[J].肾脏病与透析肾移植杂志,2018,27(6):513-517.[12]Nadeau-Fredette AC,Bargman JM.Characteristics and outcomes of fungal peritonitis in a modern North American cohort[J].Perit Dial Int,2015,35(1):78-84.

相似文献/References:

[1]林子娟,王美玲,王 芳.基于CiteSpace软件的腹膜透析护理文献计量学研究[J].医学信息,2022,35(15):32.[doi:10.3969/j.issn.1006-1959.2022.15.006]
　LIN Zi-juan,WANG Mei-lin,WANG Fang.Bibliometric Study on Peritoneal Dialysis Nursing Based on CiteSpace Software[J].Medical Information,2022,35(16):32.[doi:10.3969/j.issn.1006-1959.2022.15.006]
[2]徐海红,刘 宇,宋桂云.腹膜透析患者认知功能障碍对日常透析操作影响的研究[J].医学信息,2022,35(15):110.[doi:10.3969/j.issn.1006-1959.2022.15.025]
　XU Hai-hong,LIU Yu,SONG Gui-yun.Study on the Effect of Cognitive Dysfunction in Peritoneal Dialysis Patients on Daily Dialysis Operation[J].Medical Information,2022,35(16):110.[doi:10.3969/j.issn.1006-1959.2022.15.025]
[3]谢小街,黄凤梅,王满琴,等.氯沙坦钾片联合黄葵胶囊和贝前列素钠片对腹膜透析患者腹透液蛋白丢失的影响[J].医学信息,2019,32(24):136.[doi:10.3969/j.issn.1006-1959.2019.24.048]
　XIE Xiao-jie,HUANG Feng-mei,WANG Man-qin,et al.Effect of Losartan Potassium Tablets,Huangkui Capsules,and Beprost Sodium Tablets on Peritoneal Fluid Protein Loss in Patients with Peritoneal Dialysis[J].Medical Information,2019,32(16):136.[doi:10.3969/j.issn.1006-1959.2019.24.048]
[4]陶秀波.腹膜透析患者自我护理能力现状及影响因素分析[J].医学信息,2020,33(13):177.[doi:10.3969/j.issn.1006-1959.2020.13.057]
　TAO Xiu-bo.Analysis of Current Status and Influencing Factors of Self-care Ability of Peritoneal Dialysis Patients[J].Medical Information,2020,33(16):177.[doi:10.3969/j.issn.1006-1959.2020.13.057]
[5]徐海红,闫 巍,陈 晶,等.腹膜透析患者认知功能障碍的相关因素分析[J].医学信息,2022,35(23):80.[doi:10.3969/j.issn.1006-1959.2022.23.013]
　XU Hai-hong,YAN Wei,CHEN Jing,et al.Analysis of the Related Factors to the Cognitive Dysfunction of the Patients with Peritoneal Dialysis[J].Medical Information,2022,35(16):80.[doi:10.3969/j.issn.1006-1959.2022.23.013]
[6]骆 楠.腹膜透析患者微炎症和铁负荷的关系[J].医学信息,2021,34(09):131.[doi:10.3969/j.issn.1006-1959.2021.09.035]
　LUO Nan.The Relationship Between Microinflammation and Iron Load in Peritoneal Dialysis Patients[J].Medical Information,2021,34(16):131.[doi:10.3969/j.issn.1006-1959.2021.09.035]
[7]王 勇,张艾萍,王修全,等.半胱氨酸蛋白酶抑制剂C早期监测消化道穿孔伴腹膜炎患者并发肾功能损害的应用[J].医学信息,2021,34(12):130.[doi:10.3969/j.issn.1006-1959.2021.12.034]
　WANG Yong,ZHANG Ai-ping,WANG Xiu-quan,et al.Application of Cysteine Protease Inhibitor C in Early Monitoring of Patients with Digestive Tract Perforation and Peritonitis Complicated with Renal Function Impairment[J].Medical Information,2021,34(16):130.[doi:10.3969/j.issn.1006-1959.2021.12.034]
[8]邓雯懿,徐国玉,刘国辉.老年营养风险指数在评估维持性腹膜透析患者营养中的应用[J].医学信息,2021,34(16):47.[doi:10.3969/j.issn.1006-1959.2021.16.013]
　DENG Wen-yi,XU Guo-yu,LIU Guo-hui.Application of Elderly Nutritional Risk Index in Evaluating Nutrition of Maintenance Peritoneal Dialysis Patients[J].Medical Information,2021,34(16):47.[doi:10.3969/j.issn.1006-1959.2021.16.013]
[9]傅 强,李志樑,周柏华,等.射血分数保留的心力衰竭合并终末期肾病不同透析方式的死亡率比较[J].医学信息,2022,35(02):110.[doi:10.3969/j.issn.1006-1959.2022.02.026]
　FU Qiang,LI Zhi-liang,ZHOU Bai-hua,et al.Comparison of Mortality Rates Under Different Dialysis Methods in Patients with Heart Failure with Preserved Ejection Fraction Combined with End-stage Renal Disease[J].Medical Information,2022,35(16):110.[doi:10.3969/j.issn.1006-1959.2022.02.026]

更新日期/Last Update: 1900-01-01